Teva Canada has initiated a recall of specific Teva-Pregabalin 150 mg capsules due to potential contamination with sertraline, another pharmaceutical drug. Routine testing by the company revealed the presence of the contaminant, prompting the voluntary recall. While the extent of the contamination and potential health risks are being evaluated, Teva Canada is taking precautionary measures to ensure patient safety. The recall affects a specific batch of the medication and consumers are advised to contact their healthcare provider or pharmacist for guidance. Further details regarding affected lot numbers and instructions for returning the product are expected to be released by Teva Canada and health authorities. This recall highlights the importance of stringent quality control measures in pharmaceutical manufacturing.